Open AccessResearch Biomarkers For The Diagnosis Of Alzheimer’s Disease
Author(s) -
Shreyashi M*,
AUTHOR_ID,
D Sulagna,
G Swamynathan,
Infant Santhose B,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2019
Publication title -
international journal of engineering and advanced technology
Language(s) - English
Resource type - Journals
ISSN - 2249-8958
DOI - 10.35940/ijeat.f9363.088619
Subject(s) - disease , medicine , cerebrospinal fluid , intensive care medicine , cognitive impairment , biomarker , alzheimer's disease , pathology , biology , biochemistry
Alzheimer’s disease (AD) is a neuronal disease that is characterized by the loss of neurons and cognitive impairment. There is no definitive cure and current treatment options are focused more on reducing the damage caused by the disease and providing care for the patients. Early diagnosis of the disease will help in minimizing the damage and give better treatment options. In this review we try to analyze a few important risk factors and identify some biomarkers in blood and cerebrospinal fluid (CSF) which could be used for the diagnosis of AD